Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Despite recent advances in cancer immunotherapy, the efficacy of these therapies for the treatment of human prostate cancer patients is low due to the complex immune evasion mechanisms (IEMs) of prostate cancer and the lack of predictive biomarkers for patient responses. | Immune landscape of human prostate cancer Immune evasion mechanisms and biomarkers for personalized immunotherapy